Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
thanks
Is market open tomorrow and friday?
MYIQ- BREAK OUT ....@ 0.015
MYIQ- looks great
FNIX - news..November 25, 2003
Posted by - TelephonyWorld @ 9:26 pm PST
FONIX CONNECTME, A SPEECH-ENABLED AUTO ATTENDANT, CHOSEN BY DURHAM JONES & PINEGAR
SALT LAKE CITY, UT (November 24, 2003) Fonixr Corporation (OTC BB: FNIX), an international provider of leading speech interface solutions, has deployed its ConnectMeT telephony system in the law offices of Salt Lake City-based Durham Jones & Pinegar. Fonix ConnectMe is an efficient voice-automated telephone operator that professionally routes incoming, outgoing and internal calls.
Durham Jones & Pinegar currently uses Fonix ConnectMe to route after-hours calls to attorneys of the firm. Callers speak the name of the attorney they want to reach and are quickly connected to that person's extension. "ConnectMe has greatly improved the availability of all DJP attorneys to their clients," says Jeff Jones, attorney and partner of Durham Jones & Pinegar. "Many of our lawyers are still hard at work after the close of normal business hours. Fonix ConnectMe enables our attorneys to continue to receive calls after our operator has left for the day. The system supports DJP's philosophy of superior customer service."
By deploying Fonix ConnectMe, Durham Jones & Pinegar increases attorney efficiency. "Law firms absolutely benefit from an auto attendant solution like ConnectMe," explains Walt Nawrocki, vice president of Computer Telephony Integration (CTI) at Fonix. "By going through the ConnectMe system, clients still have after-hours access to their lawyers."
About Durham Jones & Pinegar
Durham Jones & Pinegar is one of Utah's premier law firms focusing on solving client problems in the areas of corporate and business law, real estate, tax, estate planning, intellectual property, litigation, bankruptcy and creditors' rights. Durham Jones & Pinegar has offices in Salt Lake City, Ogden, and St. George, Utah, and in Mesquite, Nevada. For more information, visit www.djplaw.com.
About Fonix
Fonix Corporation (OTC BB: FNIX) provides speech interface solutions for mobile / wireless devices, computer telephony systems, the assistive market, automobiles and everyday consumer devices. Manufacturers and developers incorporate Fonix technology to provide their customers with an easy, convenient, reliable user experience. Visit www.fonix.com for an introduction to Fonix's complete suite of speech solutions, or contact a Fonix representative at (801) 553-6600 and say "Sales."
http://www.telephonyworld.com/cgi-bin/news/viewnews.cgi?category=all&id=1069813600
i like this stock ....but just dont feel greedy today ......made some coffee money and im happy for it now ... :)
out @ 0.158 .......just got some coffee money there
ADVR- its goin to make a new 52 week high
ADVR- 0.14 wall fell down
In ADVR @ 0.137
PWRC- keep uting .....great move ..check it out
PWRC- keep uting .....great move ..check it out
PWRC- Very nice call
PWRC- great looking stock ...lvl2 looking great too
PWRC- great looking stock ...lvl2 looking great too
ALGXQ-one question ....what would be the value of the current shares for that 350 million ...thanks for sharing
NCTI- the great news would push it to a new high
NCTI-The great news will push it to a new high ..imo
BBAN-very nice one
BBAN- any thought?
buy signal in OHLC
http://trending123.com/patterns/1_2_3_buy_ohlc.htm
here is some website about how to look at AROON indicator for a bullish trend reversal.......not sure is it rite .....hope it does help someone
http://trending123.com/patterns/bullish_trend_reversal.htm
Omni- great post and gret post.....each of your educational posts makes know alot more about stock ......thanks
WTER- according to the chart ...we have the White Marubozu (White Marubozu means that the opening price is similar to the low and the closing price coincides with the high. It indicates a bullish trend, and usually becomes the first part of a bullish continuation or a bullish reversal pattern.) for friday.....looking good
WTER- omni ...any target on this one? thanks
WTER-chart (weekly view)
WTER-chart looks nice(daily view)
WTER -- WaterChef, Inc. (DE)
Com ($0.001)
Address:
1007 Glen Cove Ave.
Suite 1
Glen Head
NY 11545
USA
Phone: 516-656-0059
Officers:
David A. Conway, Pres. & CEO
Shares Outstanding: 89,559,886 as of 2003-06-01
Estimated Market Cap: 12.538M as of 2003-11-20
so POS means lie and schemes ...?
im getting more confused .... @_@
What does POS mean? thanks
omni-any thought on QTFV ?
QTFV- MACD is turning to positive and stochastic is showing oversold ...... the cloud would be clear out very soon....the news would help this puppy goes up
QTFV-QT 5 Secures First International NICOWater Distribution Agreement for South Korea
Thursday November 20, 9:00 am ET
WESTLAKE VILLAGE, Calif., Nov. 20, 2003 (PRIMEZONE) -- QT 5, Inc. (OTC BB:QTFV.OB - News), manufacturer and marketers of NICOWater(tm), the breakthrough Homeopathic Nicotinum (nicotine) product designed to relieve the symptoms of tobacco cravings, today announced that it has signed an exclusive distribution agreement with STI Distribution for the rights to market and sell NICOWater(tm) in the Republic of South Korea. With over 14 million total smokers, South Korea represents the ninth largest tobacco market in the world and a significant opportunity for the Company.
The South Korean Government recently passed revisions to the Public Health Improvement Law, which took effect July 1, banning smoking at buildings with more than 3,000 square meters of floor space and at hospitals, schools and other places where large crowds gather. In a country where a full 68% of adult males smoke, the demand for an alternative like NICOWater(tm) is tremendous and built-in.
Mr. Woo Young Kim, STI Chairman stated, ``I am honored that QT 5 has chosen my company to introduce NICOWater(tm) to the South Korean marketplace. This product is an ideal solution for millions of South Korean smokers who are suffering from the increased governmental restrictions. In addition to decreased productivity, many people are experiencing heightened anxiety from the inability to readily relieve the symptoms of tobacco cravings. STI has a strong history of fulfilling the needs of South Korea's consumers. I am confident that NICOWater(tm) will be successful everywhere that there are smokers and we are anxious to pioneer QT 5's international efforts.'
``We have proudly announced our recent successes in opening a number of leading Drug chains and regional distribution networks within the United States,' said Steven H. Reder, QT 5, Inc. President. ``The addition of our first International distributor represents a significant step in the execution of our strategic product introduction. Our company has been achieving results on many fronts and it is my conviction to continue to keep all of our constituents informed about our progress, and I look forward to subsequent announcements in the coming weeks.'
About QT 5, Inc.
QT 5, Inc. is a Delaware corporation formed in April 1999 as a manufacturer, distributor and marketer of Bio-Med testing and Homeopathic products. QT 5, Inc. currently manufactures and markets NICOWater, its breakthrough Homeopathic Nicotinum (nicotine) product designed to relieve the symptoms of tobacco cravings. QT 5 continues to do research and development regarding future products for lifestyle enhancements. QT 5, Inc. is headquartered in Westlake Village, California. For more information on the Company please visit: http://www.qt5inc.com. NICOWater(tm) is a Homeopathic Drug product that is sold under the FDA's Compliance Policy Guide Conditions Under Which Homeopathic Drugs May Be Marketed.
This press release contains forward-looking statements that involve risks, uncertainties and assumptions that, if they never materialize or prove incorrect, could cause the results of QT 5, Inc. to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations as of the date of this press release. Actual results may differ materially from those projected because of a number of risks and uncertainties, including those detailed from time to time in the reports filed by QT 5, Inc. with the Securities and Exchange Commission. QT 5, Inc. assumes no obligation and does not intend to update these forward-looking statements.
Contact:
QT 5, Inc.
Steve Reder, President
(818) 338-1510
mail to: sreder@qt5inc.com
Crier Communications
Peter Berk
(310) 274-1072, ext. 205
peter@crierpr.com
J.P. Lincoln
(310) 274-1072, ext. 201
jp@crierpr.com
--------------------------------------------------------------------------------
Source: QT 5, Inc.
BUZZ....QTFV-do u know anything about the " Phase 3 of the FDA approval process" ......how many phases are there and when is the last stage?
QT 5 Supplies Ten-Minute HIV Test for Evaluation by Dept. of Defense
Friday November 14, 9:01 am ET
WESTLAKE VILLAGE, Calif., Nov. 14 /PRNewswire-FirstCall/ -- QT 5, Inc. (OTC Bulletin Board: QTFV - News), manufacturer, distributor and marketers of biomedical diagnostics and NICOWater(TM), a Homeopathic Nicotinum Formula, today announced it has submitted their recently acquired ten-minute HIV1 and HIV2 qualitative diagnostic kit to the office of the Army's Surgeon General.
"Although our HIV test is still in Phase 3 of the FDA approval process; the word is out about the exciting potential of our entire patented diagnostic platform," said QT 5, Inc. CEO Timothy Owens. "In addition to impressive private, institutional and local government markets, the United States Federal Government represents the single largest user base for QT 5 diagnostics. It is no mistake that all of our medical, scientific and regulatory advisors are widely recognized and well respected for their influence in the advancement of the biomedical sciences. As a result of our preliminary market research, QT 5 leadership has been actively presenting our products to many high level decision makers within the Federal Government. This most recent opportunity was in response to a written request from U.S. Army's Purchasing Review Dept."
About QT 5, Inc.
QT 5, Inc. is a Delaware corporation formed in April 1999 as a manufacturer, distributor and marketer of biomedical testing and Homeopathic products. QT 5, Inc. currently manufactures and markets NICOWater, its breakthrough Homeopathic Nicotinum (nicotine) product designed to relieve the symptoms of tobacco cravings. QT 5, Inc. continues to do research and development regarding future products for lifestyle enhancements. QT 5, Inc. is headquartered in Westlake Village, California. For more information on the Company please visit: www.qt5inc.com. NICOWater(TM) is a Homeopathic Drug product that is sold under the FDA's Compliance Policy Guide Conditions Under Which Homeopathic Drugs May Be Marketed.
This press release contains forward-looking statements that involve risks, uncertainties and assumptions that, if they never materialize or prove incorrect, could cause the results of QT 5, Inc. to differ materially from those expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including any projections of earnings, revenue, or other financial items, any statements of the plans, strategies, and objectives of management for future operations, any statements concerning proposed new products, services or developments, any statements regarding future economic conditions or performance, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations as of the date of this press release. Actual results may differ materially from those projected because of a number of risks and uncertainties, including those detailed from time to time in the reports filed by QT 5, Inc. with the Securities and Exchange Commission. QT 5, Inc. assumes no obligation and does not intend to update these forward-looking statements.
--------------------------------------------------------------------------------
Source: QT 5, Inc.
QTFV-Brooks Pharmacy Chain is First to Introduce NICOWater(TM) Related Stocks
QTFV
WESTLAKE VILLAGE, Calif., May 30 /PRNewswire-FirstCall/ -- QT 5, Inc. (BULLETIN BOARD: QTFV) , manufacturer and marketers of NICOWater(TM), the breakthrough Homeopathic nicotinum (nicotine) product designed to relieve symptoms of tobacco cravings, announced that NICOWater(TM) is now available at all Brooks Pharmacy locations throughout the New England area. The company also announced that NICOWater(TM) has been shipped to Northeast Beverage Corp., Rhode Island Distributing, Providence Beverage and C & C Distributing for distribution to multiple northeastern states.
Steven Reder, President of QT 5 stated, "We believe that NICOWater(TM) is a breakthrough product whose time has come. We believe NICOWater(TM) taps directly into the $200 billion tobacco and tobacco products market. And, most importantly, we believe that NICOWater(TM) is a revolutionary Homeopathic product that will have broad commercial acceptance through all consumer channels -- from national pharmacy, convenience and grocery chains to point of use locations such as restaurants and airlines."
Mr. Reder continued, "Our dynamic management team has worked long and hard to get to this point. We chose Brooks for our regional introduction because of their strong demographics and leading edge approach to providing their customers with the most comprehensive selection of pharmacy, healthcare and lifestyle products."
In addition to high visibility in Brooks' direct and in-store advertising vehicles, the NICOWater(TM) campaign includes newspaper and radio advertising targeted specifically to Brooks Pharmacy communities announcing immediate availability. QT 5 Vice President of Marketing, Randall VyDuna, notes, "Although we intend to provide all of our resellers with strong promotional support, as 'first to market' Brooks will certainly be rewarded and benefit greatly from our introductory marketing push. As we increase the range of our marketing efforts, the message will remain constant. Whether at home with children, on an airplane or on the 30th floor, a smoker can sip a 16.9 fl. oz. bottle of NICOWater(TM) and relieve symptoms of tobacco cravings without subjecting others, especially children, to the harmful effects of second-hand smoke."
Conference Call and Webcast
Within the context of QT 5 management's commitment to maximum transparency, QT 5 will be hosting a webcast and conference call on Monday, June 2, 2003 at 11 am Eastern to discuss the successful launch and rollout of NICOWater, as well as all financial aspects of the company. Steven Reder, President of QT 5, and other members of the executive management team will be available to answer questions and discuss the current state of the Company. Investors may e-mail questions in advance of the call to A.J. Cervantes, President of Trilogy Capital Partners, at aj@trilogy-capital.com. Participants in the conference can call 800.406.5356 domestically, or by calling 913.981.5572 from an international location. Investors should indicate they are participating in the "QT 5 Guidance Call." To access the webcast, investors who would like to pre-register for the webcast can log on to www.qt5inc.com after 6 pm Eastern today.
The webcast will also be distributed over the Shareholder.com Investor Distribution Network to both institutional and individual investors including OpenCompany.info, a corporate disclosure network providing information on over 6,000 public companies to the investment community and to participating portals and websites
About NICOWater(TM)
NICOWater(TM) is designed to relieve the symptoms of tobacco cravings as is indicated in all product packaging and usage instructions. QT 5, Inc. is quite specific about who our market is: adult smokers who suffer from the symptoms of tobacco cravings and find themselves in situations or environments where smoking is prohibited or discouraged. The United States has led the world in identifying the dangers of second hand smoke. As a result, smoking restrictions are widespread and increasing rapidly. While these steps have doubtlessly eliminated many of the second-hand exposure and greatly improved numerous building environments, there remain over 40 million active smokers who must obey these growing restrictions and succumb to these inconveniences simply to relieve the symptoms of their tobacco cravings. NICOWater(TM) is a Homeopathic drug product that is sold under the FDA's Compliance Policy Guide Conditions under which Homeopathic Drugs may be Marketed. For more information, visit http://www.nicowater.com/.
About QT 5, Inc.
QT 5, Inc. is a Delaware corporation formed in April 1999 as a manufacturer, distributor and marketer of Bio-Med testing and Homeopathic products. QT 5, Inc. is continuing its clinical research and development of future products for lifestyle enhancements. QT 5, Inc. is headquartered in Westlake Village, California. For more information please visit: www.qt5inc.com. NICOWater(TM) is a Homeopathic drug product that is sold under the FDA's Compliance Policy Guide Conditions under which Homeopathic Drugs may be Marketed. For additional information on QT 5, Inc. contact Bernadette Cusack, Vice President - Investor Relations, Trilogy Capital Partners, bernadette@trilogy-capital.com.
Cautionary Statement
This release contains forward-looking statements that involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events. These statements involve estimates, assumptions, known and unknown risks, uncertainties and performances, or achievements expressed or implied by the forward-looking statement. Actual future results and trends may differ materially from those made in or suggested by any forward-looking statements due to a variety of factors, including, for example, our ability to compete with other products in our space; the risk of unfavorable federal regulation; and the fact that our status as a development state company makes our future unclear. Consequently you should not place undue reliance on these forward-looking statements. We discuss many of these and other risks and uncertainties in greater detail under the section entitled, "Risk Factors That May Affect Future Results" in Item 1 of the Company's Current Report on Form 8-K as filed with SEC on January 24, 2003 (the "Merger Form 8-K").
CONTACT: Bernadette Cusack, Vice President, Trilogy Capital Partners, Inc., +1-800-330-6540, bernadette@trilogy-capital.com, for QT 5, Inc.
Web site: http://www.nicowater.com/ http://www.qt5inc.com/
Contact
Bernadette Cusack, Vice President
Trilogy Capital Partners, Inc.
800.330.6540
bernadette@trilogy-capital.com
QTFV- the chart looks pretty good ...teh MACD is goin to posive soon
http://bigcharts.marketwatch.com/javachart/javachart.asp?symb=QTFV&time=8
QTFV- Pretty strong in last hour ...something is cooking
QTFV -O/S :The total number of shares of the registrant's Common Stock, par value $.15 per share, outstanding on November 10, 2003 was 46,614,457 (FROM:FORM 10-QSB )
UAX-uting
UAX- uting